Mental health Flashcards
Definition of delusions
Unshakeable, false beliefs that are not in keeping with an individual’s educational, cultural and social background.
Definition of hallucination
Perceptions in the absence of actual external stimuli
Schizophrenia diagnostic criteria
Includes psychotic phenomena, negative symptoms, cognitive symptoms and disorganisation. It is a chronic disorder, requiring at least 6 months of symptomatology and at least one month of psychotic symptoms. Disorders that meet the criteria for schizophrenia, but do not fulfil this timeframe, are classified as schizophreniform disorder
Psychotic disorders (schizophrenia, schizoaffective disorder, substance-induced psychosis, delusional disorder): aims of the treatment
facilitate recovery
prevent relapse, because repeated relapses are associated with poor short- and long-term outcomes
improve function, quality of life and physical health
prevent suicide
Psychotic disorder diagnosis
signs and symptoms of psychosis (including at least one positive sign or symptom) persist for at least 1 week and cause distress and functional impairment
Signs and symptoms in psychotic disorders
> Negative signs and symptoms
lack of motivation
poor self-care
blunted affect
reduced speech
social withdrawal
> Cognitive signs and symptoms
impaired planning
reduced mental flexibility
impaired memory and concentration
impaired social cognition [NB2]
> Excitement:
disorganised behaviour
aggression
hostility
catatonia
Signs and symptoms in Brief psychotic disorder
positive psychotic signs or symptoms that fully resolve within 1 month
Signs and symptoms in schizophreniform disorder
Both negative and positive signs or symptoms that fully resolve within 6 months
Signs and symptoms in substance-induced psychotic disorder
Positive psychotic signs or symptoms related to substance use that last longer than expected with intoxication or withdrawal, but less than 4 weeks
Signs and symptoms in schizophrenia
Negative and positive psychotic signs or symptoms and functional deterioration that persist for longer than 6 months
Signs and symptoms in schizoaffective disorder
Symptoms of schizophrenia with prominent mood symptoms consistent with those of major depression or bipolar disorder
Primarily experiences symptoms of psychosis, which may appear without a mood disorder. The DSM criteria require 2 weeks in which psychotic symptoms occur without mood symptoms
Signs and symptoms in Delusional disorder
Usually presents in middle to late life.
It is characterised by not bizarre delusions (grandiose, persecutory, erotomanic, somatic) lasting for at least 1 month and resulting in functional decline. Hallucinations, if present, are not prominent, and are related to the delusion
Assessment of psychotic disorders
> A comprehensive history, including:
details of the presenting symptoms
a developmental history, including details about relationships, employment, function and early life stress or trauma
family history, including mental and physical health
medical and psychiatric history, including treatment history
substance use, including alcohol, tobacco and other drugs
mental state examination
physical examination and neurological assessment; check blood pressure, heart rate, temperature and respiratory rate
investigations, including
full blood count
blood electrolytes (including calcium), creatinine and urea concentrations
liver biochemistry
blood glucose concentration
thyroid function tests
urine toxicology
inflammatory markers (eg erythrocyte sedimentation rate [ESR], C-reactive protein [CRP])
oxygen saturation (with or without blood gas measurement)
electrocardiogram (ECG)
brain imaging (eg computerised tomography [CT], magnetic resonance imaging [MRI]).
Additional assessments for people at risk of conditions associated with psychotic signs and symptoms, include:
hepatitis C serology for people at risk of hepatitis C
human immunodeficiency virus (HIV) antibody/antigen testing and syphilis serology for people at risk of a sexually transmitted infection
pain assessment in people at risk of delirium
electroencephalogram (EEG) when indicated (eg a history of head trauma, seizures)
antinuclear antibodies (ANA), N-methyl-D-aspartate (NMDA) receptor antibodies, and anti–glutamic acid decarboxylase (anti-GAD) antibodies for people at risk of autoimmune psychosis (eg NMDA receptor encephalitis); seek expert advice for further assessmen
Baseline parameters potentially affected by antipsychotic therapy
blood pressure and heart rate
weight, waist circumference and BMI
blood glucose and glycated haemoglobin (HbA1c) concentration
lipid concentrations, including triglycerides
level of physical activity
movement (involuntary or voluntary)
full blood count
blood prolactin concentration l
electrocardiogram (ECG)
Antipsychotic choice for a first episode of psychosis in adults - considerations
If antipsychotic therapy for a first episode of psychosis is considered necessary after observing the patient for 24 to 48 hours,
Amisulpride, aripiprazole, olanzapine, quetiapine, risperidone and ziprasidone have been shown in randomised controlled trials to have efficacy in treating a first episode of psychosis.
!!!!!!! Do not use olanzapine as first-line therapy for a first episode of psychosis because it has severe metabolic adverse effects.!!!!
1 amisulpride 100 mg orally, daily; increase to a target dosage of 400 to 600 mg daily in 2 divided doses [Note 5]. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 1200 mg
OR
1 aripiprazole 10 mg orally, in the morning; increase to a target dosage of 15 mg daily. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 30 mg
OR
1 quetiapine immediate-release 50 mg orally, twice daily on the first day; increase to 100 mg twice daily on the second day; increase to a target dosage of 200 mg twice daily on the third day [Note 6]. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 800 mg
OR
1 quetiapine modified-release 150 mg orally, daily on the first day; increase to 300 mg daily on the second day; increase to a target dosage of 450 mg daily on the third day [Note 6]. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 800 mg
OR
1 risperidone 1 mg orally, daily; increase to a target dosage of 2 to 4 mg daily (as a single dose or in 2 divided doses). See Monitoring and titrating and Duration of therapy. Maximum daily dose is 6 mg [Note 7]
OR
1 ziprasidone 40 mg orally, twice daily; target dosage is 40 to 60 mg twice daily. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 160 mg [Note 8]
OR
2 asenapine 5 mg sublingually, twice daily [Note 9]. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 20 mg [Note 10]
OR
2 brexpiprazole 1 mg orally, daily for 4 days, then increase to 2 mg daily; target dosage is 2 to 4 mg daily. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 4 mg
OR
2 lurasidone 40 mg orally, daily; increase to a target dosage of 80 to 120 mg daily. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 160 mg
OR
2 paliperidone modified-release 3 to 6 mg orally, daily; target dosage is 6 mg daily [Note 11]. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 12 mg
OR
3 olanzapine 5 mg orally, daily; increase to a target dosage of 10 to 15 mg daily. See Monitoring and titrating and Duration of therapy. Maximum daily dose is 20 mg [Note 12].
Duration of antipsychotic therapy for a first episode of psychosis
The minimum duration of antipsychotic therapy for a first episode of psychosis depends on the duration of symptoms and how quickly the patient responds to treatment.
If symptoms last for longer than 6 months (ie the patient has schizophrenia or schizoaffective disorder) or the patient has delusional disorder, continue antipsychotic therapy for at least 2 years after symptom resolution—a longer duration is often required.
If symptoms resolve in less than 6 months and the patient does not have delusional disorder, continue antipsychotic therapy for at least 1 year after symptom resolution—a shorter duration may be adequate if the patient rapidly responds to treatment (eg symptoms resolve in a month). Consider the impact of the episode (eg risk of suicide or violence) and its context (eg comorbid substance use, family history of psychotic disorder).
Illusion: concept
e modifications of real objects or people that can be distorted in size
(micropsia or macropsia), shape (metamorphopsia), and color (dyschromatopsia).
Illusion categorization
illusions of completion,
illusions of affect,
pareidolia,
auditory illusions,
or tactile illusions.
Illusion risk factors
epilepsy and complex or focal seizures, but these misperceptions may also occur in individuals without a medical or psychiatric diagnosis
Dellusion categorization
bizarre (e.g., aliens living in one’s
body) or non-bizarre (e.g., boss thinking about firing them).
Delusions may be persecutory (being watched by CIA),
Grandiose (just drafted as an NFL quarterback),
Erotomanic (believing a famous movie star is married to you),
Somatic (believing eggs are hatching in one’s stomach),
Delusions of reference (believing the
President’s speeches are geared toward oneself),
Delusions of control (believing the Greek gods are controlling one’s movements and thoughts).
Explain the dopamine’s hypothesis of schizophrenia’s symptoms
The dopamine hypothesis attributes the symptoms of schizophrenia to
levels of dopaminergic activity in the mesocortical and mesolimbic tracts. Subnormal levels of dopamine in
the mesocortical tract are attributed to negative symptoms, while excessive dopaminergic activity in the
mesolimbic tract is attributed to positive symptoms.
Pathophysiology of negative symptoms
Subnormal levels of dopamine in
the mesocortical tract
Pathophysiology of positive symptoms
excessive dopaminergic activity in the
mesolimbic tract
excessive dopaminergic activity in the
mesolimbic tract